ORALTAG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oraltag, and what generic alternatives are available?
Oraltag is a drug marketed by Interpharma Praha As and is included in one NDA.
The generic ingredient in ORALTAG is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.
Summary for ORALTAG
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 3,643 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ORALTAG? | ORALTAG excipients list |
DailyMed Link: | ORALTAG at DailyMed |
Pharmacology for ORALTAG
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ORALTAG
US Patents and Regulatory Information for ORALTAG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interpharma Praha As | ORALTAG | iohexol | FOR SOLUTION;ORAL | 205383-001 | Mar 26, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |